| Year |
Citation |
Score |
| 2023 |
Barreno L, Sevane N, Valdivia G, Alonso-Miguel D, Suarez-Redondo M, Alonso-Diez A, Fiering S, Beiss V, Steinmetz NF, Perez-Alenza MD, Peña L. Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity. International Journal of Molecular Sciences. 24. PMID 37762335 DOI: 10.3390/ijms241814034 |
0.347 |
|
| 2023 |
Valdivia G, Alonso-Miguel D, Perez-Alenza MD, Zimmermann ABE, Schaafsma E, Kolling FW, Barreno L, Alonso-Diez A, Beiss V, Affonso de Oliveira JF, Suárez-Redondo M, Fiering S, Steinmetz NF, Vom Berg J, Peña L, et al. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients. Cells. 12. PMID 37759464 DOI: 10.3390/cells12182241 |
0.343 |
|
| 2023 |
Kalami A, Shahgolzari M, Khosroushahi AY, Fiering S. Combining vaccination and immunogenic apoptosis to treat cancer. Immunotherapy. PMID 36852419 DOI: 10.2217/imt-2022-0137 |
0.372 |
|
| 2022 |
Najaflou M, Shahgolzari M, Khosroushahi AY, Fiering S. Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics. Cancers. 15. PMID 36612080 DOI: 10.3390/cancers15010082 |
0.355 |
|
| 2022 |
Mao C, Beiss V, Ho GW, Fields J, Steinmetz NF, Fiering S. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade. Journal For Immunotherapy of Cancer. 10. PMID 36460333 DOI: 10.1136/jitc-2022-005834 |
0.366 |
|
| 2022 |
Shahgolzari M, Dianat-Moghadam H, Yavari A, Fiering SN, Hefferon K. Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors. Vaccines. 10. PMID 36146510 DOI: 10.3390/vaccines10091431 |
0.342 |
|
| 2022 |
Shahgolzari M, Fiering S. Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies. Journal of Cancer Immunology. 4: 22-29. PMID 35600219 DOI: 10.33696/cancerimmunol.4.061 |
0.37 |
|
| 2022 |
Koellhoffer EC, Mao C, Beiss V, Wang L, Fiering SN, Boone CE, Steinmetz NF. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model. Molecular Pharmaceutics. PMID 34978197 DOI: 10.1021/acs.molpharmaceut.1c00681 |
0.349 |
|
| 2021 |
Shahgolzari M, Dianat-Moghadam H, Fiering S. Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies. Seminars in Cancer Biology. PMID 34375725 DOI: 10.1016/j.semcancer.2021.07.018 |
0.37 |
|
| 2021 |
Stump CT, Ho G, Mao C, Veliz FA, Beiss V, Fields J, Steinmetz NF, Fiering S. Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth. Cancers. 13. PMID 33562450 DOI: 10.3390/cancers13040627 |
0.321 |
|
| 2021 |
Shahgolzari M, Pazhouhandeh M, Milani M, Fiering S, Khosroushahi AY. Alfalfa mosaic virus nanoparticles-based vaccination induces antitumor immune responses in breast cancer model. Nanomedicine (London, England). 16: 97-107. PMID 33442986 DOI: 10.2217/nnm-2020-0311 |
0.379 |
|
| 2020 |
Mao C, Gorbet MJ, Singh A, Ranjan A, Fiering S. vaccination with nanoparticles for cancer immunotherapy: understanding the immunology. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 37: 4-17. PMID 33455477 DOI: 10.1080/02656736.2020.1810333 |
0.388 |
|
| 2020 |
Gorbet MJ, Singh A, Mao C, Fiering S, Ranjan A. Using nanoparticles for vaccination against cancer: mechanisms and immunotherapy benefits. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 37: 18-33. PMID 33426995 DOI: 10.1080/02656736.2020.1802519 |
0.329 |
|
| 2020 |
Fiering SN, Ho GW. Speed Kills: Advancement in Th17 Cell Adoptive Cell Therapy for Solid Tumors. Cancer Research. 80: 3795-3796. PMID 32934025 DOI: 10.1158/0008-5472.Can-20-2306 |
0.395 |
|
| 2020 |
Shukla S, Wang C, Beiss V, Cai H, Washington T, Murray AA, Gong X, Zhao Z, Masarapu H, Zlotnick A, Fiering S, Steinmetz NF. The unique potency of Cowpea mosaic virus (CPMV) cancer vaccine. Biomaterials Science. PMID 32914796 DOI: 10.1039/D0Bm01219J |
0.415 |
|
| 2020 |
Soetaert F, Korangath P, Serantes D, Fiering S, Ivkov R. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies. Advanced Drug Delivery Reviews. 65-83. PMID 32603814 DOI: 10.1016/J.Addr.2020.06.025 |
0.352 |
|
| 2020 |
Shahgolzari M, Pazhouhandeh M, Milani M, Khosroushahi AY, Fiering S. Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology. 12. PMID 32249552 DOI: 10.1002/Wnan.1629 |
0.323 |
|
| 2020 |
Sethuraman SN, Singh MP, Patil G, Li S, Fiering S, Hoopes PJ, Guha C, Malayer J, Ranjan A. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity. Theranostics. 10: 3397-3412. PMID 32206098 DOI: 10.7150/Thno.42243 |
0.445 |
|
| 2019 |
Wang C, Fiering SN, Steinmetz NF. Cowpea Mosaic Virus Promotes Anti-Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model. Advanced Therapeutics. 2. PMID 33969181 DOI: 10.1002/adtp.201900003 |
0.376 |
|
| 2019 |
Sheen MR, Fields JL, Northan B, Lacoste J, Ang LH, Fiering S, Iorns E, Tsui R, Denis A, Perfito N, Errington TM. Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Elife. 8. PMID 31845647 DOI: 10.7554/Elife.45120 |
0.666 |
|
| 2019 |
Singh MP, Sethuraman SN, Ritchey J, Fiering S, Guha C, Malayer J, Ranjan A. In-situ vaccination using focused ultrasound heating and anti-CD-40 agonistic antibody enhances T-cell mediated local and abscopal effects in murine melanoma. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 36: 64-73. PMID 31795832 DOI: 10.1080/02656736.2019.1663280 |
0.367 |
|
| 2019 |
Duval KEA, Vernice NA, Wagner RJ, Fiering SN, Petryk JD, Lowry GJ, Tau SS, Yin J, Houde GR, Chaudhry AS, Hoopes PJ. Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 36: 37-46. PMID 31795829 DOI: 10.1080/02656736.2019.1627433 |
0.336 |
|
| 2019 |
Albakri MM, Veliz FA, Fiering SN, Steinmetz NF, Sieg SF. Endosomal toll-like receptors play a key role in activation of primary human monocytes by Cowpea Mosaic Virus. Immunology. PMID 31630392 DOI: 10.1111/Imm.13135 |
0.353 |
|
| 2019 |
Murray AA, Sheen MR, Veliz FA, Fiering SN, Steinmetz NF. In Situ Vaccination of Tumors Using Plant Viral Nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 2000: 111-124. PMID 31148013 DOI: 10.1007/978-1-4939-9516-5_10 |
0.695 |
|
| 2018 |
Alexander MP, Fiering SN, Ostroff GR, Cramer RA, Mullins DW. Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung. Cancer Immunology, Immunotherapy : Cii. PMID 30167860 DOI: 10.1007/S00262-018-2234-9 |
0.356 |
|
| 2018 |
Murray AA, Wang C, Fiering S, Steinmetz NF. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma. Molecular Pharmaceutics. PMID 29798673 DOI: 10.1021/Acs.Molpharmaceut.8B00316 |
0.488 |
|
| 2018 |
Patel R, Czapar AE, Fiering S, Oleinick NL, Steinmetz NF. Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression. Acs Omega. 3: 3702-3707. PMID 29732445 DOI: 10.1021/acsomega.8b00227 |
0.369 |
|
| 2018 |
Sheen MR, Fiering S. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1524. PMID 29667346 DOI: 10.1002/Wnan.1524 |
0.741 |
|
| 2018 |
Hoopes PJ, Wagner RJ, Duval K, Kang K, Gladstone DJ, Moodie KL, Crary-Burney M, Ariaspulido H, Veliz FA, Steinmetz NF, Fiering S. Treatment of canine oral melanoma with nanotechnology-based immunotherapy and radiation. Molecular Pharmaceutics. PMID 29613803 DOI: 10.1021/Acs.Molpharmaceut.8B00126 |
0.453 |
|
| 2017 |
Hoopes PJ, Wagner RJ, Song A, Osterberg B, Gladstone DJ, Bursey AA, Fiering SN, Giustini AJ. The effect of hypofractionated radiation and magnetic nanoparticle hyperthermia on tumor immunogenicity and overall treatment response. Proceedings of Spie--the International Society For Optical Engineering. 10066. PMID 29515284 DOI: 10.1117/12.2255981 |
0.399 |
|
| 2017 |
Hoopes PJ, Mazur CM, Osterberg B, Song A, Gladstone DJ, Steinmetz NF, Veliz FA, Bursey AA, Wagner RJ, Fiering SN. Effect of intra-tumoral magnetic nanoparticle hyperthermia and viral nanoparticle immunogenicity on primary and metastatic cancer. Proceedings of Spie--the International Society For Optical Engineering. 10066. PMID 29203952 DOI: 10.1117/12.2256062 |
0.491 |
|
| 2017 |
Hoopes PJ, Moodie KL, Petryk AA, Petryk JD, Sechrist S, Gladstone DJ, Steinmetz NF, Veliz FA, Bursey AA, Wagner RJ, Rajan A, Dugat D, Crary-Burney M, Fiering SN. Hypo-fractionated Radiation, Magnetic Nanoparticle Hyperthermia and a Viral Immunotherapy Treatment of Spontaneous Canine Cancer. Proceedings of Spie--the International Society For Optical Engineering. 10066. PMID 29203951 DOI: 10.1117/12.2256213 |
0.435 |
|
| 2017 |
Mastria EM, Cai LY, Kan MJ, Li X, Schaal JL, Fiering S, Gunn MD, Dewhirst MW, Nair SK, Chilkoti A. Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29146246 DOI: 10.1016/J.Jconrel.2017.11.021 |
0.469 |
|
| 2017 |
Lee KL, Murray AA, Le DHT, Sheen MR, Shukla S, Commandeur U, Fiering S, Steinmetz NF. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response. Nano Letters. PMID 28650644 DOI: 10.1021/Acs.Nanolett.7B00107 |
0.713 |
|
| 2017 |
Fiering S. Cancer immunotherapy: Making allies of phagocytes. Nature Nanotechnology. 12: 615-616. PMID 28436962 DOI: 10.1038/Nnano.2017.89 |
0.361 |
|
| 2017 |
Sheen MR, Fiering S. Exploiting Uptake of Nanoparticles by Phagocytes for Cancer Treatment. Methods in Molecular Biology (Clifton, N.J.). 1530: 355-367. PMID 28150214 DOI: 10.1007/978-1-4939-6646-2_22 |
0.736 |
|
| 2017 |
Varn FS, Wang Y, Mullins DW, Fiering SN, Cheng C. Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment. Cancer Research. PMID 28126714 DOI: 10.1158/0008-5472.Can-16-2490 |
0.456 |
|
| 2016 |
Varn FS, Mullins DW, Arias-Pulido H, Fiering S, Cheng C. Adaptive immunity programs in breast cancer. Immunology. PMID 27564847 DOI: 10.1111/Imm.12664 |
0.442 |
|
| 2016 |
Allegrezza MJ, Rutkowski MR, Stephen TL, Svoronos N, Tesone AJ, Perales-Puchalt A, Nguyen JM, Sarmin F, Sheen MR, Jeng EK, Tchou J, Wong HC, Fiering SN, Conejo-Garcia JR. IL-15 AGONISTS OVERCOME THE IMMUNOSUPPRESSIVE EFFECTS OF MEK INHIBITORS. Cancer Research. PMID 26980764 DOI: 10.1158/0008-5472.Can-15-2808 |
0.697 |
|
| 2016 |
Rahme GJ, Zhang Z, Young AL, Cheng C, Bivona EJ, Fiering SN, Hitoshi Y, Israel MA. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-mediated Survival of Proneural Glioma Cells. Cancer Research. PMID 26951930 DOI: 10.1158/0008-5472.Can-15-2157 |
0.351 |
|
| 2016 |
Lee KL, Twyman RM, Fiering S, Steinmetz NF. Virus-based nanoparticles as platform technologies for modern vaccines. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 26782096 DOI: 10.1002/Wnan.1383 |
0.373 |
|
| 2016 |
Lizotte PH, Wen AM, Sheen MR, Fields J, Rojanasopondist P, Steinmetz NF, Fiering S. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Nature Nanotechnology. 11: 295-303. PMID 26689376 DOI: 10.1038/Nnano.2015.292 |
0.718 |
|
| 2016 |
Lizotte P, Wen A, Steinmetz N, Fiering S. Abstract A140: Viral-like nanoparticles for tumor immunotherapy by in situ vaccination mediate potent antitumor immunity Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A140 |
0.51 |
|
| 2015 |
Sheen MR, Warner SL, Fields JL, Conejo-Garcia JR, Fiering S. Myristoylated p110α Causes Embryonic Death Due to Developmental and Vascular Defects. Open Life Sciences. 10: 461-478. PMID 27482546 DOI: 10.1515/Biol-2015-0048 |
0.662 |
|
| 2015 |
Jukosky J, Gosselin BJ, Foley L, Dechen T, Fiering S, Crane-Godreau MA. In vivo Cigarette Smoke Exposure Decreases CCL20, SLPI, and BD-1 Secretion by Human Primary Nasal Epithelial Cells. Frontiers in Psychiatry. 6: 185. PMID 26793127 DOI: 10.3389/Fpsyt.2015.00185 |
0.305 |
|
| 2015 |
Ndong C, Toraya-Brown S, Kekalo K, Baker I, Gerngross TU, Fiering SN, Griswold KE. Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo. International Journal of Nanomedicine. 10: 2595-617. PMID 25878495 DOI: 10.2147/Ijn.S79367 |
0.305 |
|
| 2015 |
Sheen MR, Fields JL, Northan B, Lacoste J, Ang L, Fiering S, Iorns E, Tsui R, Denis A, Perfito N, Errington TM. Author response: Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis Elife. DOI: 10.7554/Elife.04796.003 |
0.692 |
|
| 2015 |
Sheen MR, Warner SL, Fields JL, Conejo-Garcia JR, Fiering S. Myristoylated p110α Causes Embryonic Death Due to Developmental and Vascular Defects Open Life Sciences. 10: 461-478. DOI: 10.1515/biol-2015-0048 |
0.595 |
|
| 2015 |
Lizotte P, Sheen MR, Wen AM, Steinmetz NF, Fiering S. Abstract A68: Local tumor treatments to simulate systemic antitumor immune responses Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A68 |
0.721 |
|
| 2015 |
Lizotte PH, Wen AM, Sheen MR, Fields J, Rojanasopondist P, Steinmetz NF, Fiering S. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer Nature Nanotechnology. DOI: 10.1038/nnano.2015.292 |
0.675 |
|
| 2014 |
Lizotte PH, Baird JR, Stevens CA, Lauer P, Green WR, Brockstedt DG, Fiering SN. Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis. Oncoimmunology. 3: e28926. PMID 25083323 DOI: 10.4161/Onci.28926 |
0.46 |
|
| 2014 |
Sheen MR, Lizotte PH, Toraya-Brown S, Fiering S. Stimulating antitumor immunity with nanoparticles Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 6: 496-505. PMID 25069691 DOI: 10.1002/Wnan.1274 |
0.721 |
|
| 2014 |
Rutkowski MR, Allegrezza MJ, Svoronos N, Tesone AJ, Stephen TL, Perales-Puchalt A, Nguyen J, Zhang PJ, Fiering SN, Tchou J, Conejo-Garcia JR. Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer. Journal of Visualized Experiments : Jove. PMID 24748051 DOI: 10.3791/51171 |
0.412 |
|
| 2014 |
Toraya-Brown S, Sheen MR, Zhang P, Chen L, Baird JR, Demidenko E, Turk MJ, Hoopes PJ, Conejo-Garcia JR, Fiering S. Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1273-85. PMID 24566274 DOI: 10.1016/J.Nano.2014.01.011 |
0.714 |
|
| 2014 |
Busch AM, Galimberti F, Nehls KE, Roengvoraphoj M, Sekula D, Li B, Guo Y, Direnzo J, Fiering SN, Spinella MJ, Robbins DJ, Memoli VA, Freemantle SJ, Dmitrovsky E. All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched. Cancer Biology & Therapy. 15: 463-72. PMID 24496080 DOI: 10.4161/Cbt.27821 |
0.317 |
|
| 2013 |
Baird JR, Fox BA, Sanders KL, Lizotte PH, Cubillos-Ruiz JR, Scarlett UK, Rutkowski MR, Conejo-Garcia JR, Fiering S, Bzik DJ. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Research. 73: 3842-51. PMID 23704211 DOI: 10.1158/0008-5472.Can-12-1974 |
0.449 |
|
| 2013 |
Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP, Sheen MR, Fox BA, Bzik DJ, Bosenberg M, Mullins DW, Turk MJ, Fiering S. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. Journal of Immunology (Baltimore, Md. : 1950). 190: 469-78. PMID 23225891 DOI: 10.4049/Jimmunol.1201209 |
0.737 |
|
| 2013 |
Toraya-Brown S, Sheen MR, Baird JR, Barry S, Demidenko E, Turk MJ, Hoopes PJ, Conejo-Garcia JR, Fiering S. Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 159-71. PMID 22935885 DOI: 10.1039/C2Ib20180A |
0.737 |
|
| 2013 |
Fiering S, Baird JR, Fox B, Lizotte P, Sanders K, Conjeo-Garcia J, Bzik D. Abstract B21: Immune-based treatment of ovarian cancer in a mouse model with attenuated Toxoplasma gondii. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B21 |
0.48 |
|
| 2013 |
Fiering S, Baird JR, Byrne K, Lizotte P, Mullins D, turk MJ. Abstract A36: Treatment of established dermal murine B16F10 melanoma with an attenuatedToxoplasma gondiieliminates the treated tumor and stimulates systemic antitumor immunity. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A36 |
0.454 |
|
| 2012 |
Scarlett UK, Rutkowski MR, Rauwerdink AM, Fields J, Escovar-Fadul X, Baird J, Cubillos-Ruiz JR, Jacobs AC, Gonzalez JL, Weaver J, Fiering S, Conejo-Garcia JR. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. The Journal of Experimental Medicine. 209: 495-506. PMID 22351930 DOI: 10.1084/Jem.20111413 |
0.454 |
|
| 2012 |
Cubillos-Ruiz JR, Baird JR, Tesone AJ, Rutkowski MR, Scarlett UK, Camposeco-Jacobs AL, Anadon-Arnillas J, Harwood NM, Korc M, Fiering SN, Sempere LF, Conejo-Garcia JR. Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. Cancer Research. 72: 1683-93. PMID 22307839 DOI: 10.1158/0008-5472.Can-11-3160 |
0.341 |
|
| 2009 |
Cubillos-Ruiz JR, Fiering S, Conejo-Garcia JR. Nanomolecular targeting of dendritic cells for ovarian cancer therapy. Future Oncology (London, England). 5: 1189-92. PMID 19852731 DOI: 10.2217/Fon.09.101 |
0.407 |
|
| Show low-probability matches. |